DIA
BMY icon

Dean Investment Associates’s Bristol-Myers Squibb BMY Stock Holding History

Dean Investment Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Sell
42,649
-2,903
-6% -$167K 0.32% 135
2026
Q1 		$2.76M Buy
45,552
+1,785
+4% +$104K 0.39% 128
2025
Q4 		$2.36M Sell
43,767
-5,971
-12% -$287K 0.34% 133
2025
Q3 		$2.24M Sell
49,738
-1,980
-4% -$92.5K 0.31% 138
2025
Q2 		$2.39M Buy
51,718
+1,045
+2% +$51.3K 0.35% 139
2025
Q1 		$3.09M Sell
50,673
-3,620
-7% -$211K 0.46% 97
2024
Q4 		$3.07M Sell
54,293
-24,503
-31% -$1.37M 0.44% 99
2024
Q3 		$4.08M Sell
78,796
-5,499
-7% -$258K 0.55% 63
2024
Q2 		$3.5M Sell
84,295
-3,116
-4% -$139K 0.5% 79
2024
Q1 		$4.74M Buy
87,411
+16,648
+24% +$848K 0.65% 52
2023
Q4 		$3.63M Sell
70,763
-14,987
-17% -$787K 0.52% 84
2023
Q3 		$4.98M Buy
85,750
+850
+1% +$52.1K 0.82% 30
2023
Q2 		$5.43M Buy
84,900
+17,777
+26% +$1.19M 0.88% 30
2023
Q1 		$4.65M Buy
67,123
+5,314
+9% +$375K 0.74% 45
2022
Q4 		$4.45M Buy
61,809
+7,002
+13% +$528K 0.76% 42
2022
Q3 		$3.9M Buy
54,807
+727
+1% +$52.7K 0.79% 37
2022
Q2 		$4.16M Sell
54,080
-22,493
-29% -$1.71M 0.81% 29
2022
Q1 		$5.59M Buy
76,573
+1,092
+1% +$73.3K 1% 13
2021
Q4 		$4.71M Sell
75,481
-2,516
-3% -$148K 0.83% 30
2021
Q3 		$4.62M Sell
77,997
-610
-0.8% -$40.2K 0.87% 23
2021
Q2 		$5.25M Sell
78,607
-121
-0.2% -$7.89K 0.97% 13
2021
Q1 		$4.97M Sell
78,728
-745
-0.9% -$46.4K 0.94% 13
2020
Q4 		$4.93M Sell
79,473
-3,456
-4% -$213K 1.02% 7
2020
Q3 		$5M Sell
82,929
-1,536
-2% -$92.4K 1.2% 6
2020
Q2 		$4.97M Sell
84,465
-469
-0.6% -$28.1K 1.19% 6
2020
Q1 		$4.73M Sell
84,934
-557
-0.7% -$34K 1.01% 10
2019
Q4 		$5.49M Sell
85,491
-28,680
-25% -$1.64M 0.86% 24
2019
Q3 		$5.79M Buy
114,171
+1,026
+0.9% +$48.2K 0.85% 27
2019
Q2 		$5.13M Buy
113,145
+71,342
+171% +$3.32M 0.74% 47
2019
Q1 		$1.99M Buy
+41,803
New +$2.08M 0.29% 131

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dean Investment Associates's BMY Position: Q2 2026 in Review

Dean Investment Associates reduced its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, selling an estimated $167K and leaving 42,649 shares worth $2.46M. The position accounts for 0.32% of the portfolio, ranked #135.

Dean Investment Associates first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.79M in Q3 2019. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Dean Investment Associates held 42,649 shares of Bristol-Myers Squibb worth $2.46M as of Q2 2026.
  • Dean Investment Associates sold 2,903 Bristol-Myers Squibb shares in Q2 2026, an estimated $167K.
  • Bristol-Myers Squibb made up 0.32% of Dean Investment Associates's portfolio in Q2 2026, its #135 holding.
  • Dean Investment Associates first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
  • Dean Investment Associates's Bristol-Myers Squibb position peaked at $5.79M in Q3 2019.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.